Marjorie Neidecker, PhD, MEng, RN, CCRP
Assistant Professor of Clinical Nursing; Director, Master of Applied Clinical and Preclinical Research Program
Room 210, 760 Kinnear Rd
760 Kinnear Road, Columbus, OH 43212
Kitzmiller JP, Phelps MA, Neidecker MV, Apseloff G. Establishing a clinical pharmacology fellowship program for physicians, pharmacists, and pharmacologists: a newly-accredited interdisciplinary training program at the Ohio State University. Advances in Medical Education and Practice 2014 Jun 23;5:191-6. doi: 10.2147/AMEP.S60986.
Patel A, Reardon G, Nelson W, Philpot T, Neidecker M. Persistence of Warfarin Therapy for Residents in Long-term Care Who Have Atrial Fibrillation. Clinical Therapeutics 2013;35(11):1794-804.
Reardon G, Nelson WW, Patel AA, Philpot T, Neidecker M. Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding risk. Drugs and Aging. 2013 June;30(6):417–428.
Reardon G, Patel A, Nelson W, Philpot T, Neidecker M. Usage of medications with high potential to interact with warfarin among atrial fibrillation residents in long-term care facilities. Expert Opinion in Pharmacotherapy 2013;14(2):165-73.
Reardon G, Nelson W, Patel AA, Philpot T, Neidecker M. Prevalence of Atrial Fibrillation in U.S. Nursing Homes: Results from the National Nursing Home Survey 1985–2004. Journal of the American Medical Directors Association (JAMDA) 2012 Jul;13(6):529-34.
Neidecker M, Patel AA, Nelson WW, Reardon G. Use of Warfarin in Long-Term Care: A Systematic Review. BMC Geriatrics 2012;12:14. “Highly accessed” article designation.
Levine DA, Neidecker MV, Kiefe CI, Karve S, Williams LS, Allison JJ. Racial and Ethnic Disparities in Access to Physician Care and Medications among US Stroke Survivors: The National Health Interview Survey Years 2000 to 2006. Neurology. 2011;76(1):53-61.
Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics. 2009;27(6):451-464.